WOUND HEALING ACCELERATION USING NATURAL PRODUCTS

使用天然产品加速伤口愈合

基本信息

  • 批准号:
    2810705
  • 负责人:
  • 金额:
    $ 10.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-05-01 至 2003-04-30
  • 项目状态:
    已结题

项目摘要

This renewal proposal describes an interdisciplinary, systematic and targeted study of Peruvian plants with cicatrizant (wound-healing) activity. Although cicatrizant plants constitute the main focus of this proposal, extracts will also be screened for potential antineoplasic activity. The diverse topography, semitropical climate and unique cultural heritage of Peru contribute to making this country a desirable place for bioprospecting. Cicatrizant agents could help patients with illness such as diabetes, gastric ulcers or varicose ulcers, whose wounds do not scar easily. Notwithstanding these medical benefits, the scientific study of wound-healing plants may help uncover whether a connection can be established between injuries, healing and the treatment of proliferative disorders. Recent work has uncovered evidence that strengthens a correlation between injury and carcinogenesis. The study of cicatrizant plants and the mechanisms by which their active principle(s) operate, will reveal natural agents capable of promoting tissue regeneration. This investigation will shed light on externally promoted healing mechanisms triggered by acute and, perhaps chronic, injury. A five-step approach to wound-healing natural products has been designed: 1. Characterization of the active principle from Anredera diffusa and bioassay-guided fractionation of Jatropa curcas latex. The former was isolated during the previous grant period. 2. Structure-activity relationship studies on taspine and (+)-anymol, the two cicatrizant principles found in Croton lechleri and Peperomia galioides, respectively. The latter was isolated and identified during the previous grant period. 3. Cell migration and cell proliferation studies to probe mechanism of action for cicatrizant principles found in Peperomia galioides, Anredera diffusa and Jatropa curcas. 4. Characterization of the active principle from an extract who failed to show in vivo wound-healing activity during the previous grant period but tested positive in our anticancer screening assay. This corresponds to a potential topoisomerase II inhibitor from Campsiandra angustifolia. 5. Scientific evaluation of crude extracts from newly identified Peruvian plants with cicatrizant and anticancer activity. The long-term objective of this research is to strengthen the international and multidisciplinary collaboration between scientists from Peru and the United States, with the aim of linking conservation of biological diversity with sustained economic management of medicinal plants needed for the discovery and development of pharmaceuticals to improve human health.
这个更新建议描述了一个跨学科的,系统的和有针对性的研究秘鲁植物的愈合(伤口愈合)活动。虽然植物具有愈合作用

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GERALD B HAMMOND其他文献

GERALD B HAMMOND的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GERALD B HAMMOND', 18)}}的其他基金

Nucleophilic Halogenation Reagents
亲核卤化试剂
  • 批准号:
    9707486
  • 财政年份:
    2016
  • 资助金额:
    $ 10.75万
  • 项目类别:
Nucleophilic halogenation reagents
亲核卤化试剂
  • 批准号:
    10058844
  • 财政年份:
    2016
  • 资助金额:
    $ 10.75万
  • 项目类别:
Transition metal catalyzed construction of ring systems
过渡金属催化构建环系
  • 批准号:
    8290765
  • 财政年份:
    2012
  • 资助金额:
    $ 10.75万
  • 项目类别:
ISOLATION OF BIOACTIVE COMPOUNDS FROM PERUVIAN PLANTS
从秘鲁植物中分离生物活性化合物
  • 批准号:
    2097683
  • 财政年份:
    1993
  • 资助金额:
    $ 10.75万
  • 项目类别:

相似海外基金

Infectious Diseases Training program in Bolivia: South-South Training with Peru
玻利维亚传染病培训项目:与秘鲁的南南培训
  • 批准号:
    10838920
  • 财政年份:
    2024
  • 资助金额:
    $ 10.75万
  • 项目类别:
Peru Vanderbilt – PREvention through VacciNation Training (PREVENT) program
秘鲁范德比尔特 — 通过疫苗接种培训进行预防 (PREVENT) 计划
  • 批准号:
    10674393
  • 财政年份:
    2023
  • 资助金额:
    $ 10.75万
  • 项目类别:
Innovations in Implementing Decentralized HIV Services in Peru
秘鲁实施分散式艾滋病毒服务的创新
  • 批准号:
    10762842
  • 财政年份:
    2023
  • 资助金额:
    $ 10.75万
  • 项目类别:
Doctoral Dissertation Research: The Impact of the Miraflores El Niño Flood on the Chiribaya of Far Southern Peru
博士论文研究:米拉弗洛雷斯厄尔尼诺洪水对秘鲁远南奇里巴亚的影响
  • 批准号:
    2306152
  • 财政年份:
    2023
  • 资助金额:
    $ 10.75万
  • 项目类别:
    Standard Grant
The cultural legacy of Paralympic media in Peru: Lessons from the Global South
秘鲁残奥会媒体的文化遗产:来自南方国家的经验教训
  • 批准号:
    2788972
  • 财政年份:
    2023
  • 资助金额:
    $ 10.75万
  • 项目类别:
    Studentship
HIVR4P 2023, the 5th HIV Research for Prevention Conference, Lima, Peru, and virtually, 22-26 October 2023
HIVR4P 2023,第五届艾滋病毒预防研究会议,秘鲁利马,虚拟会议,2023 年 10 月 22-26 日
  • 批准号:
    10617933
  • 财政年份:
    2023
  • 资助金额:
    $ 10.75万
  • 项目类别:
Building Inclusive Recovery through Theatre (BIRTh): people with autism going beyond the COVID-19 pandemic in Peru
通过剧院构建包容性康复 (BIRTh):自闭症患者超越秘鲁的 COVID-19 大流行
  • 批准号:
    AH/X008576/1
  • 财政年份:
    2023
  • 资助金额:
    $ 10.75万
  • 项目类别:
    Research Grant
Open Doors? Cross-border itineraries of Venezuelan migrants in Colombia, Ecuador & Peru
开门?
  • 批准号:
    2881461
  • 财政年份:
    2023
  • 资助金额:
    $ 10.75万
  • 项目类别:
    Studentship
Socio-structural barriers and older adults' therapeutic itineraries to access healthcare during the COVID- 19 pandemic in Peru
秘鲁 COVID-19 大流行期间的社会结构障碍和老年人获得医疗保健的治疗行程
  • 批准号:
    2750490
  • 财政年份:
    2022
  • 资助金额:
    $ 10.75万
  • 项目类别:
    Studentship
Focal mass drug administration (fMDA) to reduce Plasmodium vivax transmission, a pragmatic cluster randomized controlled trial in Peru
旨在减少间日疟原虫传播的集中集中药物管理(fMDA),这是秘鲁的一项实用整群随机对照试验
  • 批准号:
    10488139
  • 财政年份:
    2022
  • 资助金额:
    $ 10.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了